Aprecia, Cycle Pharmaceuticals Partner for 3-D Printing of Orphan Drugs
By

By
Aprecia Pharmaceuticals, a Langhorne, Pennsylvania-based specialty pharmaceutical company with a three-dimensional printing (3DP) platform, and Cycle Pharmaceuticals, a Cambridge, England-based pharmaceutical company, have signed a partnership agreement to develop and…

FDA Approves Pfizer’s Biosimilar of J&J’s Remicade
By

By
The US Food and Drug Administration (FDA) has approved Pfizer’s Ixifi (infliximab-qbtx) as a biosimilar to Johnson & Johnson’s (J&J) Remicade (infliximab), an anti-inflammatory drug, for all eligible indications of…

Teva Announces 25% Reduction in Global Workforce, Further Restructuring
By

By
Teva Pharmaceutical Industries has announced a detailed two-year restructuring plan that includes a reduction of 25% of its workforce or 14,000 positions globally, closures or divestments of research and development…

Lilly, Bayer, J&J, and Merck & Co. Lead Pipeline News
By

By
A roundup of the latest market developments from the pipelines of the pharmaceutical majors, featuring news from Lilly, Johnson&Johnson, and Merck & Co. Editor’s Note: This article was updated on…

Teva, Novo Nordisk, and Sanofi Lead Drug Approval News
By

By
A roundup of the latest drug approvals, including from the pharmaceutical majors, featuring news from Teva, Novo Nordisk, and Sanofi. Editor’s Note: This article was updated on a continuous basis…

Oxford Genetics, MeiraGTx in Gene-Therapy Supply Pact
By

By
Oxford Genetics, an Oxford, England-headquartered synthetic biology-based technology company, has signed an agreement with MeiraGTx, a London, UK-based clinical-stage gene therapy company, to develop adeno-associated virus (AAV) vectors as well…

Abzena in ADC Supply Pact
By

By
Abzena, a contract manufacturer of biologics and antibody drug conjugates, has entered into a master services agreement with an undisclosed US biotechnology company to provide process development and manufacturing services…

Novo Nordisk, Torrent Open Expanded Insulin Manufacturing Plant in India
By

By
Novo Nordisk India and Torrent Pharmaceuticals, Novo’s Ahmedabad, India-headquartered manufacturing partner, have opened an extended insulin manufacturing facility at Torrent’s Indrad, India factory. Torrent and Novo Nordisk have been partnered…

Granules Pharmaceuticals Receives One Observation from FDA Inspection
By

By
Granules Pharmaceuticals, a Hyderabad, India-headquartered pharmaceutical company, has completed its first inspection by the US Food and Drug Administration of its manufacturing facility in Chantilly, Virginia. The inspection took place…

European and UK Pharma Industry Outline Priorities in Next Round of Brexit Talks
By

By
Following the announcement by UK and European Union (EU) authorities of the progress made in Phase One of the negotiations between the UK and EU over the UK’s withdrawal from…